Go Back
Crinetics Pharmaceuticals, Inc. Reports annual revenue of $4.0 million
By USInMinutes - Mar 06, 2024, 09:40 AM ET
Last Updated - Mar 06, 2024, 09:40 AM EST
Company Records $214.5 million loss
Crinetics Pharmaceuticals, Inc. [CRNX] has reported $4.0 million in revenue for year ended Dec 31, 2023.
Also Read:
Sponsored
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $214.5 million.
Also Read:
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Based in San Diego, California, Crinetics Pharmaceuticals, Inc. operates in the Manufacturing sector.
Related Articles:
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications
Sponsored
Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMSRead More from Annual Reports
Read More from USinMinutes
Popular News
Latest News